DMDaniel T. MacLeod
Daniel T. MacLeod
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Daniel T. MacLeod has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Armin Hekele
Precision BioSciences, Durham, NC 27701, USA
2 shared publications- Bruce McCreedy
Precision BioSciences, Inc., 302 East Pettigrew Street, Durham, NC 27701, USA
2 shared publications Caitlin A. Turner
Precision BioSciences, Durham, NC 27701, USA
2 shared publicationsClayton W. Beard
Precision BioSciences, Durham, NC 27701, USA
2 shared publicationsDerek Jantz
Precision BioSciences, Durham, NC 27701, USA
2 shared publicationsJanel Lape
Precision BioSciences, Durham, NC 27701, USA
2 shared publications
Latest Publications
- Open Access
- 1 April 2017
- Published by Elsevier in Molecular Therapy
- Vol. 25 (4) , 949-961
Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells
- 1 April 2017
- Published by Elsevier in Molecular Therapy
- Vol. 25 (4) , 949-961
Open AccessIntegration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells
- Open Access
- 1 May 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24, S156
394. Generation of a Novel Allogeneic CAR T Cell Platform Utilizing an Engineered Meganuclease and AAV Donor Template to Achieve Efficient Disruption of T Cell Receptor Expression and Simultaneous Homology-Directed Insertion of a CD19 CAR
- 1 May 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24, S156
Open Access394. Generation of a Novel Allogeneic CAR T Cell Platform Utilizing an Engineered Meganuclease and AAV Donor Template to Achieve Efficient Disruption of T Cell Receptor Expression and Simultaneous Homology-Directed Insertion of a CD19 CAR